CEO of EGeen International speaks at the 8th Annual C21 Bioventures Conference
Mountain View, CA. - April 17, 2006. Kalev Kask, the CEO of EGeen International, will be discussing opportunities of international strategies to speed up the drug development times and to lower the cost of bringing new medicines to the market as an invited panelist at the 8th Annual C21 Bioventures Conference on May 25, 2006, in Monterey, California. C21 Bioventures Conferences (www.techvision.com/c21) is a premier networking meeting series bringing together biotech executives, entrepreneurs and venture capitalists for partnering and investment opportunities. EGeen International Corporation |